VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

Current stock price

34.33 USD
+1.18 (+3.56%)
At close:
34.27 USD
-0.06 (-0.17%)
After Hours:

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. VCYT Profitability Analysis

1.1 Basic Checks

  • VCYT had positive earnings in the past year.
  • VCYT had a positive operating cash flow in the past year.
  • In multiple years VCYT reported negative net income over the last 5 years.
  • Of the past 5 years VCYT 4 years had a positive operating cash flow.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • VCYT has a better Return On Assets (4.72%) than 90.89% of its industry peers.
  • VCYT has a better Return On Equity (5.07%) than 90.89% of its industry peers.
  • The Return On Invested Capital of VCYT (4.59%) is better than 90.12% of its industry peers.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of VCYT (12.83%) is better than 91.67% of its industry peers.
  • VCYT has a better Operating Margin (15.14%) than 91.86% of its industry peers.
  • VCYT's Gross Margin of 70.10% is fine compared to the rest of the industry. VCYT outperforms 79.46% of its industry peers.
  • In the last couple of years the Gross Margin of VCYT has grown nicely.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

8

2. VCYT Health Analysis

2.1 Basic Checks

  • VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, VCYT has more shares outstanding
  • VCYT has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 17.51. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • VCYT has a better Altman-Z score (17.51) than 86.24% of its industry peers.
  • VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.51
ROIC/WACC0.48
WACC9.55%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 8.15. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT has a better Current ratio (8.15) than 72.48% of its industry peers.
  • VCYT has a Quick Ratio of 7.81. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT has a better Quick ratio (7.81) than 70.93% of its industry peers.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. VCYT Growth Analysis

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
  • Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.01% in the last year.
  • Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 34.50% on average per year.
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.69% on average over the next years. This is quite good.
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue Next Year13.07%
Revenue Next 2Y12.71%
Revenue Next 3Y11.92%
Revenue Next 5Y10.69%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

5

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.36, the valuation of VCYT can be described as expensive.
  • 90.89% of the companies in the same industry are more expensive than VCYT, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (27.42), we can say VCYT is valued expensively.
  • With a Price/Forward Earnings ratio of 32.39, VCYT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 92.44% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, VCYT is valued a bit more expensive.
Industry RankSector Rank
PE 41.36
Fwd PE 32.39
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaply inside the industry as 92.44% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 95.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.54
EV/EBITDA 22.72
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • VCYT's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y22.38%
EPS Next 3Y19.54%

0

5. VCYT Dividend Analysis

5.1 Amount

  • No dividends for VCYT!.
Industry RankSector Rank
Dividend Yield 0%

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (4/24/2026, 8:13:02 PM)

After market: 34.27 -0.06 (-0.17%)

34.33

+1.18 (+3.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners110.9%
Inst Owner Change-0.01%
Ins Owners0.91%
Ins Owner Change7.49%
Market Cap2.73B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target49.52 (44.25%)
Short Float %8.05%
Short Ratio6.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)-1.29%
PT rev (3m)-0.37%
EPS NQ rev (1m)41.85%
EPS NQ rev (3m)10.09%
EPS NY rev (1m)-8.37%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.76%
Valuation
Industry RankSector Rank
PE 41.36
Fwd PE 32.39
P/S 5.27
P/FCF 21.54
P/OCF 20.01
P/B 2.08
P/tB 6.02
EV/EBITDA 22.72
EPS(TTM)0.83
EY2.42%
EPS(NY)1.06
Fwd EY3.09%
FCF(TTM)1.59
FCFY4.64%
OCF(TTM)1.72
OCFY5%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1.49
PEG (5Y)N/A
Graham Number17.5437 (-48.9%)
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 17.51
F-Score8
WACC9.55%
ROIC/WACC0.48
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y27.72%
EPS Next 2Y22.38%
EPS Next 3Y19.54%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year13.07%
Revenue Next 2Y12.71%
Revenue Next 3Y11.92%
Revenue Next 5Y10.69%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.27%
EBIT Next 3Y58.21%
EBIT Next 5Y37.84%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT Fundamental Analysis FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 5 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


Can you provide the profitability details for VERACYTE INC?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the financial health for VCYT stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.